A detailed history of Citigroup Inc transactions in Omnicell, Inc stock. As of the latest transaction made, Citigroup Inc holds 58,238 shares of OMCL stock, worth $2.56 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
58,238
Previous 41,455 40.48%
Holding current value
$2.56 Million
Previous $1.12 Million 126.29%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$25.61 - $45.43 $429,812 - $762,451
16,783 Added 40.48%
58,238 $2.54 Million
Q2 2024

Aug 12, 2024

BUY
$26.22 - $32.65 $140,775 - $175,297
5,369 Added 14.88%
41,455 $1.12 Million
Q1 2024

May 10, 2024

BUY
$26.15 - $37.33 $190,528 - $271,986
7,286 Added 25.3%
36,086 $1.05 Million
Q4 2023

Feb 09, 2024

BUY
$29.24 - $45.81 $195,440 - $306,194
6,684 Added 30.22%
28,800 $1.08 Million
Q3 2023

Nov 09, 2023

BUY
$44.6 - $73.38 $129,072 - $212,361
2,894 Added 15.06%
22,116 $996,000
Q2 2023

Aug 10, 2023

BUY
$57.88 - $75.94 $717,596 - $941,504
12,398 Added 181.68%
19,222 $1.42 Million
Q1 2023

May 11, 2023

SELL
$51.51 - $60.43 $77,934 - $91,430
-1,513 Reduced 18.15%
6,824 $400,000
Q4 2022

Feb 09, 2023

SELL
$46.24 - $90.03 $136,731 - $266,218
-2,957 Reduced 26.18%
8,337 $420,000
Q3 2022

Nov 10, 2022

SELL
$84.23 - $117.38 $955,420 - $1.33 Million
-11,343 Reduced 50.11%
11,294 $983,000
Q2 2022

Aug 10, 2022

SELL
$105.64 - $129.11 $2.39 Million - $2.92 Million
-22,644 Reduced 50.01%
22,637 $2.58 Million
Q1 2022

May 12, 2022

SELL
$120.68 - $180.51 $242,928 - $363,366
-2,013 Reduced 4.26%
45,281 $5.86 Million
Q4 2021

Feb 10, 2022

SELL
$153.26 - $183.62 $12 Million - $14.4 Million
-78,503 Reduced 62.4%
47,294 $8.54 Million
Q3 2021

Nov 10, 2021

BUY
$141.84 - $160.88 $17.8 Million - $20.2 Million
125,797 New
125,797 $18.7 Million

Others Institutions Holding OMCL

About OMNICELL, Inc


  • Ticker OMCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 44,288,800
  • Market Cap $1.94B
  • Description
  • Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensi...
More about OMCL
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.